|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/00 | |
| A61K 47/10 | |||
| A61K 47/18 | |||
| A61K 47/26 | |||
| A61K 47/54 | |||
| A61K 38/27 | |||
| A61P 5/06 |
| (11) | Patento numeris | 2981282 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14715022.1 |
| Europos patento paraiškos padavimo data | 2014-04-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-02-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-11-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/056819 |
| Data | 2014-04-04 |
| (87) | Numeris | WO 2014/166836 |
| Data | 2014-10-16 |
| (30) | Numeris | Data | Šalis |
| 13162480 | 2013-04-05 | EP | |
| 201361821890 P | 2013-05-10 | US | |
| 13184957 | 2013-09-18 | EP | |
| 201361879956 P | 2013-09-19 | US |
| (72) |
NIELSEN, Jette, DK
ESKLING, Marie, DK
CHRISTENSEN, Stina Granzau, DK
H JBY, Michael, DK
OLSEN, Minna Bręndholt, DK
|
| (73) |
Novo Nordisk Health Care AG,
Thurgauerstrasse 36/38 8050 Zürich,
CH
|
| (54) | GROWTH HORMONE COMPOUND FORMULATION |
| GROWTH HORMONE COMPOUND FORMULATION |